Ryan Specialty Holdings, Inc. (NYSE:RYAN) Stock Holdings Lifted by Marshall Wace LLP

Marshall Wace LLP lifted its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 251.2% in the 4th quarter, Holdings Channel reports. The fund owned 192,726 shares of the company’s stock after buying an additional 137,853 shares during the period. Marshall Wace LLP’s holdings in Ryan Specialty were worth $12,365,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Rakuten Securities Inc. purchased a new stake in shares of Ryan Specialty in the fourth quarter worth approximately $27,000. Principal Securities Inc. boosted its stake in shares of Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after buying an additional 415 shares during the period. Mizuho Bank Ltd. acquired a new stake in shares of Ryan Specialty during the 4th quarter valued at $49,000. Headlands Technologies LLC grew its holdings in shares of Ryan Specialty by 2,644.8% during the 4th quarter. Headlands Technologies LLC now owns 796 shares of the company’s stock valued at $51,000 after acquiring an additional 767 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd acquired a new position in shares of Ryan Specialty in the fourth quarter worth $54,000. Institutional investors and hedge funds own 84.82% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on RYAN. Barclays dropped their target price on Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating on the stock in a research report on Friday, April 11th. Keefe, Bruyette & Woods cut their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 9th. TD Cowen started coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They issued a “buy” rating and a $89.00 target price for the company. Royal Bank of Canada reduced their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday, February 21st. Finally, Wells Fargo & Company reduced their price target on Ryan Specialty from $69.00 to $66.00 and set an “equal weight” rating for the company in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, Ryan Specialty has an average rating of “Hold” and an average price target of $75.67.

Insider Buying and Selling

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm’s stock in a transaction dated Monday, January 27th. The shares were sold at an average price of $65.25, for a total value of $2,283,750.00. Following the completion of the sale, the director now owns 6,209 shares in the company, valued at approximately $405,137.25. This trade represents a 84.93 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 106,894 shares of company stock worth $7,107,220 in the last three months. Insiders own 11.10% of the company’s stock.

Ryan Specialty Trading Down 4.3 %

Shares of RYAN opened at $67.57 on Tuesday. The stock’s 50-day moving average price is $70.47 and its 200 day moving average price is $68.99. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 12-month low of $48.48 and a 12-month high of $77.16. The firm has a market capitalization of $17.70 billion, a price-to-earnings ratio of 97.93, a P/E/G ratio of 1.19 and a beta of 0.66.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. As a group, research analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 4th. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a yield of 0.71%. Ryan Specialty’s payout ratio is 69.57%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.